Chinese drugmaker fined $162M in antitrust case; Perrigo makes 2 animal-health deals in growth push;

@FiercePharma: German pricing watchdog didn't like Bayer's data on Eylea. No add'l benefit, IQWiG says. Bayer will respond. Report | Follow @FiercePharma

@EricPFierce: Greece urged to take new twist on compulsory licenses to get hands on cheaper drugs. Story | Follow @EricPFierce

> North China Pharmaceutical Group plans to appeal a $162 million fine on antitrust charges related to vitamin C exports to the U.S. Report (sub. req.)

> Two animal health acquisitions put over-the-counter drugmaker Perrigo in line to grow in that market and sell vet drugs in retail stores. Report

> Teva Pharmaceutical Industries ($TEVA) agreed to pay $2.3 million for violations of air and water pollution laws in Mexico, Missouri. Report

> Bayer sued Glenmark Pharmaceuticals after the Indian company asked FDA to approved its copycat version of Bayer's rosacea treatment Finacea. Report

> To fight a decline in pharma exports, Ireland needs to tweak its tax rules to make it even more attractive to drugmakers, an industry export told the Independent. Report

Medical Device News

 @FierceMedDev: Med tech incubator InCube Labs raises $30M in Texas expansion. More | Follow @FierceMedDev

 @MarkHFierce: The cosmetic laser industry is consolidating, in a deal that is pretty big (for the device industry. Release | Follow @MarkHFierce

 @DamianFierce: India wants to launch two independent committees to make sure clinical trials are ethical. Story | Follow @DamianFierce

> Will Panasonic sell its healthcare division for $1.05B? News

> FDA intensifies warning on Stryker's Neptune devices. More

> Molecular biosensor diagnoses cancer by spotting high lactate levels. Story

Biotech News

 @FierceBiotech: New special report: Biopharma's Top R&D Spenders - 2012. Report | Follow @FierceBiotech

@JohnCFierce: Updated AstraZeneca story. They buried the news on job cuts, thousands of relocations. Major upheaval. Story | Follow @JohnCFierce

@RyanMFierce: CRO buys chunk of mobile outfit behind virtual Pfizer trial. Article | Follow @RyanMFierce

> AstraZeneca axes more staffers, relocates thousands in global R&D reshuffle. Story

> FDA readies final decisions on four big biotech drugs. More

> Genomics player Illumina whacked with hefty patent case loss. Article

CRO News

> Sunshine Biopharma on the hunt for CMO partner. Item

> India deepens effort to regulate clinical trials. Article

> Ex-Aptuit researcher convicted of cooking Roche, AZ data. More

> BioClinica, CoreLab merge after buyouts. Report

> After CRO sell-off, Radiant doubles down on trial sites. Story

Biotech IT News

> CRO buys chunk of mobile outfit behind virtual Pfizer trial. Story

> BioClinica CEO: No cuts planned after CoreLab merger, private equity sale. Report

> Spiral Genetics scores $3M VC round from major backer. Item

> Novartis eyes cancer patients with two mobile apps for iPhone, Android. Article

> Genomic analysis startup scores VA contract for major study. More

And Finally... An Indian pharma company's warehouse was gutted in a fire after drums full of solvent sparked into flame. Report

Suggested Articles

The triple combo era in cystic fibrosis is here thanks to Vertex' new OK. Five months ahead of schedule, the FDA green-lighted Trikafta Monday.

On the heels of settling bellwether cases for $45 million, Teva is offering $250 million cash and $23 billion in drugs to end all its opioid lawsuits.

Under assault in the anti-inflammatory market, J&J has focused on expanding Stelara beyond dermatology—and it just took a big step in that direction.